How’s your gut these days?
If you say ‘great’, then we can assume that:
If that’s not you, don’t worry. As you’ll discover in this article, there’s a probiotic you’re probably not familiar with that could transform your life.
Wait – you may want to know that the market for these live organisms is expected to exceed $64 billion by 2023.
So, if you don’t feel like reviewing the thousands of probiotics out there, you could consider trying Lactobacillus Rhamnosus Gorbach-Goldin (Lactobacillus Rhamnosus GG, or LGG)?
After all, it is the top well-researched probiotic strain and is also the most trusted, safe, and effective probiotic currently known [1-3].
Some of the impressive health benefits of Lactobacillus Rhamnosus GG are as follows:
Lactobacillus Rhamnosus GG could help nutrient absorption run smoothly by breaking down, or fermenting, sugars that occur naturally in foods such as legumes, fruits, vegetables, nuts, and dairy.
Lactic acid is produced during this fermentation process and has been found to:
With over 400 studies documenting its immune-modulating properties, Lactobacillus Rhamnosus GG has been nicknamed ‘the vitamin C’ of probiotics.
Researchers discovered that this probiotic could help [9-14]:
All these actions decrease the number of lesions and permeability of the gut cells. A gut that is highly permeable paves the way for a host of issues including autoimmune conditions, allergies, skin, and neurocognitive disorders.
Did you know that your brain and gut are linked?
So, if your gut is unhealthy, it will favor the production of inflammatory substances. These can cross the blood-brain barrier and trigger symptoms of depression, anxiety, agitation, and mood issues.
Besides working on your diet and lifestyle, taking Lactobacillus Rhamnosus GG could help alleviate your symptoms.
Research indicates that this probiotic can act as a psychobiotic, a live organism that is able to positively alter brain balance by:
Before you try another probiotic, keep in mind that Lactobacillus Rhamnosus GG has been extensively studied. This could save you from unknowingly buying an expensive product that doesn’t work. Or worse, getting a product that could wreak havoc on your health.
Papizadeh, Moslem & Nahrevanian, Hossein & Rohani, Mahdi & Hosseini, seyed Nezamedin & Shojaosadati, Seyed. (2016). Lactobacillus rhamnosus Gorbach-Goldin (GG): A Top Well-Researched Probiotic Strain. Journal of Medical Bacteriology. 5. 46-59.
Segers, M. E., & Lebeer, S. (2014, August). Towards a better understanding of Lactobacillus rhamnosus GG-host interactions. In Microbial cell factories (Vol. 13, No. 1, p. S7). BioMed Central.
Gorbach, S., Doron, S., & Magro, F. (2017). Chapter 7: Lactobacillus rhamnosus GG. In The Microbiota in Gastrointestinal Pathophysiology (pp. 79-88).
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014). Gut microbiota, the pharmabiotics they produce and host health. Proceedings of the Nutrition Society, 73(4), 477-489.
Bergqvist, S. W., Andlid, T., & Sandberg, A. S. (2006). Lactic acid fermentation stimulated iron absorption by Caco-2 cells is associated with increased soluble iron content in carrot juice. British Journal of Nutrition, 96(4), 705-711.
Winkler, P., De Vrese, M., Laue, C., & Schrezenmeir, J. (2005). Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology & Therapeutics, 43(7).
Duncan, S. H., Louis, P., & Flint, H. J. (2004). Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Applied and environmental microbiology, 70(10), 5810-5817.
LeBlanc, J. G., Chain, F., Martín, R., Bermúdez-Humarán, L. G., Courau, S., & Langella, P. (2017). Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microbial cell factories, 16(1), 79.
Zocco, M. A., Dal Verme, L. Z., Cremonini, F., Piscaglia, A. C., Nista, E. C., Candelli, M., ... & Armuzzi, A. (2006). Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Alimentary pharmacology & therapeutics, 23(11), 1567-1574.
Rosenfeldt, V., Benfeldt, E., Nielsen, S. D., Michaelsen, K. F., Jeppesen, D. L., Valerius, N. H., & Paerregaard, A. (2003). Effect of probiotic Lactobacillus strains in children with atopic dermatitis. Journal of Allergy and Clinical Immunology, 111(2), 389-395.
Khailova, L., Baird, C. H., Rush, A. A., McNamee, E. N., & Wischmeyer, P. E. (2013). Lactobacillus rhamnosus GG improves outcome in experimental pseudomonas aeruginosa pneumonia: potential role of regulatory T cells. Shock (Augusta, Ga.), 40(6), 496.
Kekkonen, R. A., Lummela, N., Karjalainen, H., Latvala, S., Tynkkynen, S., Järvenpää, S., ... & Korpela, R. (2008). Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World journal of gastroenterology: WJG, 14(13), 2029.
Zhang, L., Li, N., Caicedo, R., & Neu, J. (2005). Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-α–induced interleukin-8 production in caco-2 cells. The Journal of nutrition, 135(7), 1752-1756.
Yan, F., Cao, H., Cover, T. L., Whitehead, R., Washington, M. K., & Polk, D. B. (2007). Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology, 132(2), 562-575.
Maghsood, F., Mirshafiey, A., Farahani, M. M., Modarressi, M. H., Jafari, P., & Motevaseli, E. (2018). Dual Effects of Cell Free Supernatants from Lactobacillus acidophilus and Lactobacillus rhamnosus GG in Regulation of MMP-9 by Up-Regulating TIMP-1 and Down-Regulating CD147 in PMA-Differentiated THP-1 Cells. Cell Journal (Yakhteh), 19(4), 559.
Sarkar, A., Lehto, S. M., Harty, S., Dinan, T. G., Cryan, J. F., & Burnet, P. W. (2016). Psychobiotics and the manipulation of bacteria–gut–brain signals. Trends in neurosciences, 39(11), 763-781.
Pärtty, A., Kalliomäki, M., Wacklin, P., Salminen, S., & Isolauri, E. (2015). A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatric research, 77(6), 823.
Mohammadi, A. A., Jazayeri, S., Khosravi-Darani, K., Solati, Z., Mohammadpour, N., Asemi, Z., ... & Eghtesadi, S. (2016). The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutritional neuroscience, 19(9), 387-395.
Sudo, N. (2016). Chapter 13: The Hypothalamic-Pituitary-Adrenal Axis and Gut Microbiota: A Target for Dietary Intervention? In The Microbiota in Gastrointestinal Pathophysiology (pp. 293–304).
Young, S. N. (2007). How to increase serotonin in the human brain without drugs. Journal of psychiatry & neuroscience: JPN, 32(6), 394.
Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., ... & Leone, P. (2014). Effect of Lactobacillus rhamnosus CGMCC1. 3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition, 111(8), 1507-1519.
Waigankar, S. S., & Patel, V. (2011). Role of probiotics in urogenital healthcare. Journal of mid-life health, 2(1), 5.
Cribby, S., Taylor, M., & Reid, G. (2008). Vaginal microbiota and the use of probiotics. Interdisciplinary perspectives on infectious diseases, 2008.
Panduru, M., Panduru, N. M., Sălăvăstru, C. M., & Tiplica, G. S. (2015). Probiotics and primary prevention of atopic dermatitis: a meta‐analysis of randomized controlled studies. Journal of the European Academy of Dermatology and Venereology, 29(2), 232-242.
Kalliomaki, M., Salminen, S., & Isolauri, E. (2016). Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. Современная педиатрия, (2), 42-45.